Home    eJManager.com Add Your Journal   |    Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Research

Vet World. 2010; 3(6): 272-274


Efficacy of various antiprotozoal drugs on bovine babesiosis, anaplasmosis and thileriosis

Nasreen Akhter, Chamon Lal, Javaid Ali Gadahi, Khuda Bux Mirbahar, and Mohammad Ismail Memon.

Cited by (1)

Abstract
The present study was conducted to check out the efficacy of various antiprotozoal drugs on bovine babesiosis, anaplasmosis and theleriosis. 38 buffaloes naturaly infected with anaplasma, babesia and theileria were selected and divided into four groups. Group A (10), B (10), C (08) and D (10) infected with anaplasmosis, babesiosis, theileriosis, and Infected Control (anaplasmosis (4), anaplasmosis + babesiosis (1 each), babesiosis (2) and theileriosis (2) respectively. Group A was further subdivided into A-I (5 animals with pure Anaplasmosis) and A-II (5 animals with mixed infection of Anaplasmosis and Babesiosis). Group-A was treated with a single dose of imidocarb dipropionate (3 mg / kg body weight). In Group A-I one animal recovered completely, 02 moderately while remaining 02 animals did not respond. The later 02 animals recovered completely after additional 02 doses of 4 mg/kg body weight. In case of group A-II complete recovery was recorded in one animal, moderate recovery in three animals while one animal showed no responsel. Group B was treated with Diminazene acceturate (3. 5 mg / kg body weight) administered as a single dose. 6 animals recovered completely, 02 moderately while 02 animals showed no response. Group C was treated with a single dose of Buparvaqune (2.5 mg / kg body weight), complete recovery was recorded in 4 animals, 2 animals showed no response, while 2 animals with severe infection died after 24 hrs.

Key words: Babesiosis, anaplasmosis, theileriosis, drug efficacy, buffalo


Full text links

Share this Article





ScopeMed Home
Follow ScopeMed on Twitter
Job Opportunities/Service Offers
About ScopeMed
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of eJManager LLC Publishing for Scientific Publications. Copyright © ScopeMedź International Medical Journal Management and Indexing System.
Scopemed Buttons